Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04287075 · ClinicalTrials.gov registry record

Surgical Treatment of Chronic Neuropathic Pain

A clinical trial, sponsored by Axogen Corporation.

Terminated
Registry status
8
Enrollment target

NCT04287075 is a clinical trial that was terminated before completion, run by Axogen Corporation. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04287075 was terminated before completion, sponsored by Axogen Corporation.

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

Observational registry study assessing the subject's pain history and the impact of surgery for the treatment of chronic neuropathic pain by comparing post-operative outcomes (pain level, pain medication usage, quality of life outcomes, and nerve functional outcome) to pre-operative levels.

Interventions

  • PROCEDURE Surgical Management of Neuroma

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2020-02-19
Est. Completion 2024-01-24

Sponsor

Axogen Corporation

10 total trials

What the Registry Record Tells You About NCT04287075

The ClinicalTrials.gov registry entry for NCT04287075 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Surgical Management of Neuroma is the first listed.

NCT04287075 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04287075 about?

NCT04287075 is a clinical study titled "Surgical Treatment of Chronic Neuropathic Pain". Observational registry study assessing the subject's pain history and the impact of surgery for the treatment of chronic neuropathic pain by comparing post-operative outcomes (pain level, pain medication usage, quality of life outcomes, and nerve functional outcome) to pre-operative levels.

What is the current status of trial NCT04287075?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2020-02-19. Estimated completion is 2024-01-24.

What interventions are being tested in trial NCT04287075?

The interventions under investigation include: Surgical Management of Neuroma (PROCEDURE).

Who is sponsoring clinical trial NCT04287075?

This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.